Send a letter
русская версия

Center for Immunotherapy and Cell-Based Technologies

Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main →

Multiple sclerosis

T-cell vaccination (autovaccination) for autoimmune diseases

http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml

21.02.2012 Scientists have discovered a molecular mechanism that could help explain how multiple sclerosis (MS) and other autoimmune diseases can be exacerbated ...

19.02.2012 A team of scientists from the Scripps Research Institute, collaborating with members of the drug discovery company Receptos, has created the first hig...

01.02.2012 A drug used to treat multiple sclerosis may also be effective at preventing and reversing the leading cause of heart attack, a new study has found. S...

19.01.2012 Neuroscientists at Kessler Foundation have documented increased cerebral activation in patients with multiple sclerosis (MS) following memory retraini...

19.01.2012 For the first time ever, stem cells from umbilical cords have been converted into other types of cells, which may eventually lead to new treatment opt...

11.01.2012 The discovery of a gene that causes a form of hereditary spastic paraplegia (HSP) may provide scientists with an important insight into what causes ax...

10.01.2012 New research highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The study is published...

03.01.2012 An article published Friday Dec. 23 in the December 2011 issue of The Quarterly Review of Biology argues that multiple sclerosis, long viewed as prim...

22.12.2011 Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme reported top-line results from TENERE, a Phase III clinical trial comparing the effect...

18.12.2011 Medical researchers at the University of Alberta have discovered a new way to track the progression of multiple sclerosis (MS) in those living with th...


Immunotherapy for autoimmune disease

The autovaccination-based technology exploits natural immunoregulatory mechanisms and is aimed to stimulate patient's immune reactions directed selectively against the pathogenic, selfreactive T lymphocytes responsible for disease development.

T-cell vaccination (autovaccination) for autoimmune diseases